{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:12:24Z","timestamp":1775045544377,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cllc.2025.12.009","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:45:33Z","timestamp":1768031133000},"page":"126-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thoracic Radiotherapy and Radiation Time Would Affect the Efficacy of Advanced Non-Small Cell Lung Cancer for Patients Who Responded to TKIs Treatment"],"prefix":"10.1016","volume":"27","author":[{"given":"Ma","family":"Jinbo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Pengfei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma","family":"Xiaoyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Hongxing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.cllc.2025.12.009_bib0001","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"Qiu","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.cllc.2025.12.009_bib0002","article-title":"NCCN clinical practice guidelines in oncology (NCCN guidelines): Non-small cell lung cancer (Version 3.2023)","author":"National Comprehensive Cancer Network","year":"2023","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"10.1016\/j.cllc.2025.12.009_bib0003","doi-asserted-by":"crossref","first-page":"l5460","DOI":"10.1136\/bmj.l5460","article-title":"Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta-analysis","volume":"367","author":"Zhao","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.cllc.2025.12.009_bib0004","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1186\/s12885-018-4283-z","article-title":"Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial","volume":"18","author":"Mark\u00f3czy","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.cllc.2025.12.009_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cllc.2025.12.009_bib0006","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1186\/s12885-021-08983-2","article-title":"Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study","volume":"21","author":"Miyawaki","year":"2021","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.cllc.2025.12.009_bib0007","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.21037\/tlcr-21-530","article-title":"Detection of epidermal growth factor receptor (EGFR) mutations from preoperative circulating tumor DNA (ctDNA) as a prognostic predictor for stage I\u2013III non-small cell lung cancer (NSCLC) patients with baseline tissue EGFR mutations","volume":"10","author":"Guo","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.cllc.2025.12.009_bib0008","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2017.12.012","article-title":"Strategies and technical challenges for imaging oligometastatic disease: recommendations from the European Organisation for Research and Treatment of Cancer Imaging Group","volume":"91","author":"deSouza","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2025.12.009_bib0009","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1186\/s12885-021-08983-2","article-title":"Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study","volume":"21","author":"Miyawaki","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cllc.2025.12.009_bib0010","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231161411","article-title":"Survival benefit of thoracic radiotherapy plus EGFR-TKIs in patients with non-oligometastatic advanced non-small-cell lung cancer: a single-center retrospective study","volume":"15","author":"Zhou","year":"2023","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"10.1016\/j.cllc.2025.12.009_bib0011","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.radonc.2017.10.005","article-title":"Receipt of thoracic radiation therapy and radiotherapy dose are correlated with outcomes in a retrospective study of three hundred and six patients with extensive stage small-cell lung cancer","volume":"125","author":"Xu","year":"2017","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.cllc.2025.12.009_bib0012","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.21037\/tlcr-24-414","article-title":"Narrative review of stereotactic body radiation therapy combined with tyrosine kinase inhibitors for oligometastatic EGFR-mutated non-small cell lung cancer: present and future developments","volume":"13","author":"Zhao","year":"2024","journal-title":"Transl Lung Cancer Res"},{"issue":"16","key":"10.1016\/j.cllc.2025.12.009_bib0013","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.3390\/cancers14163983","article-title":"Ablative radiotherapy as a strategy to overcome TKI resistance in EGFR-mutated NSCLC","volume":"14","author":"Novak","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.cllc.2025.12.009_bib0014","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1002\/cam4.4192","article-title":"EGFR-mutated stage IV non-small cell lung cancer: what is the role of radiotherapy combined with TKI?","volume":"10","author":"Liu","year":"2021","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.cllc.2025.12.009_bib0015","doi-asserted-by":"crossref","first-page":"e786","DOI":"10.1016\/j.cllc.2021.03.004","article-title":"Management of oligometastasis and oligoprogression in patients with epidermal growth factor receptor mutation-positive NSCLC in the era of third-generation tyrosine kinase inhibitors","volume":"22","author":"Lim","year":"2021","journal-title":"Clin Lung Cancer"},{"issue":"10","key":"10.1016\/j.cllc.2025.12.009_bib0016","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1007\/s00432-021-03831-z","article-title":"Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a real-world study","volume":"148","author":"Wei","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.cllc.2025.12.009_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103760","article-title":"Comparison of the efficacy and safety of first-line treatments based on clinicopathological characteristics for patients with advanced epidermal growth factor receptor mutated non-small-cell lung cancer: a systematic review and network meta-analysis","volume":"177","author":"Yang","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cllc.2025.12.009_bib0018","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12967-019-2035-8","article-title":"Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer","volume":"17","author":"Shishido","year":"2019","journal-title":"J Transl Med"},{"issue":"10","key":"10.1016\/j.cllc.2025.12.009_bib0019","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/bios11100394","article-title":"Liquid biopsy-based biosensors for MRD detection and treatment monitoring in non-small cell lung cancer (NSCLC)","volume":"11","author":"Sardarabadi","year":"2021","journal-title":"Biosensors (Basel)"},{"key":"10.1016\/j.cllc.2025.12.009_bib0020","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1186\/s12885-021-08983-2","article-title":"Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study","volume":"21","author":"Miyawaki","year":"2021","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.cllc.2025.12.009_bib0021","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.21037\/tlcr-20-1152","article-title":"Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies\u2014a narrative review","volume":"10","author":"Fallet","year":"2021","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"10.1016\/j.cllc.2025.12.009_bib0022","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.cllc.2025.12.009_bib0023","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.prro.2023.04.004","article-title":"Treatment of oligometastatic non-small cell lung cancer: an ASTRO\/ESTRO clinical practice guideline","volume":"13","author":"Iyengar","year":"2023","journal-title":"Pract Radiat Oncol"},{"issue":"7","key":"10.1016\/j.cllc.2025.12.009_bib0024","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/cancers11070923","article-title":"Intrinsic resistance to EGFR-tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: differences and similarities with acquired resistance","volume":"11","author":"Santoni-Rugiu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cllc.2025.12.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109769","article-title":"The impact of local control on widespread progression and survival in oligometastasis-directed SBRT: results from a large international database","volume":"186","author":"Cao","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2025.12.009_bib0026","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231161411","article-title":"Survival benefit of thoracic radiotherapy plus EGFR-TKIs in patients with non-oligometastatic advanced non-small-cell lung cancer: a single-center retrospective study","volume":"15","author":"Zhou","year":"2023","journal-title":"Ther Adv Med Oncol"},{"issue":"10","key":"10.1016\/j.cllc.2025.12.009_bib0027","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1007\/s00432-021-03831-z","article-title":"Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a real-world study","volume":"148","author":"Wei","year":"2022","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730425003377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730425003377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:13:56Z","timestamp":1775042036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730425003377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1525730425003377"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2025.12.009","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thoracic Radiotherapy and Radiation Time Would Affect the Efficacy of Advanced Non-Small Cell Lung Cancer for Patients Who Responded to TKIs Treatment","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2025.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}